This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Insperity, Inc. (NSP) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Insperity, Inc. (NSP) delivered earnings and revenue surprises of 7.66% and 0.79%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Insperity, Kforce and Cross Country Healthcare
by Zacks Equity Research
Insperity, Kforce and Cross Country Healthcare have been highlighted in this Industry Outlook article.
3 Staffing Services Stocks to Watch Amid Industry Headwinds
by Zacks Equity Research
The Zacks Staffing industry stands to benefit from the resumption of business activities, increased dependency on technology and benefits related to the ongoing hybrid working model. NSP, KFRC and CCRN are well poised to witness a demand surge.
Zacks.com featured highlights Insperity, Microchip Technology, Darden Restaurants, Dr. Reddy's and W.W. Grainger
by Zacks Equity Research
Insperity, Microchip Technology, Darden Restaurants, Dr. Reddy's and W.W. Grainger have been highlighted in this Screen of The Week article.
5 Top-Ranked Dividend Growth Stocks to Buy Now
by Sweta Killa
Insperity (NSP), Microchip Technology (MCHP), Darden Restaurants (DRI), Dr. Reddys (RDY) and W.W. Grainger (GWW) could be compelling picks for investors.
Find 'Strong Buy' Stocks that Boast Impressive Return on Equity
by Benjamin Rains
Instead of trying to chase some of the big tech names and high-growth stocks that have surged in 2023, investors might be better served to buy companies that have proven they can turn assets into profits, especially with a possible recession looming.
Insperity, Inc. (NSP) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Insperity, Inc. (NSP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights include Lamb Weston, NeoGenomics, Surrozen, KE Holdings and Insperity
by Zacks Equity Research
Lamb Weston, NeoGenomics, Surrozen, KE Holdings and Insperity are part of the Zacks Screen of the Week article.
5 Top Stocks Likely to Come Up With Earnings Beat
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next releases. Tap Lamb Weston (LW), NeoGenomics (NEO), Surrozen (SRZN), KE Hodlings (BEKE) and Insperity (NSP).
Mastercard's (MA) New Offering to Boost Cross-Border Services Suite
by Zacks Equity Research
Mastercard (MA) introduces Cross-Border Services Express so that consumers and businesses of all sizes can benefit from enhanced and hassle-free cross-border payments.
Here's What Could Help Insperity, Inc. (NSP) Maintain Its Recent Price Strength
by Zacks Equity Research
Insperity, Inc. (NSP) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Best Income Stocks to Buy for April 12th
by Zacks Equity Research
PPG and NSP made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 12, 2023.
Insperity (NSP) Gains From Growing PEO Industry, Costs High
by Zacks Equity Research
Rising number of worksite employees and pertaining employee-friendly behavior support Insperity (NSP) despite rising costs.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Reasons to Retain Insperity (NSP) Stock in Your Portfolio
by Zacks Equity Research
Insperity's (NSP) business is currently benefiting from strength in the professional employer organization or the PEO industry.
Insperity (NSP) Q4 Earnings Beat Estimates, Surge Y/Y
by Zacks Equity Research
Insperity (NSP) fourth-quarter 2022 earnings and revenues surge year over year.
Insperity, Inc. (NSP) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
Insperity, Inc. (NSP) delivered earnings and revenue surprises of 32.97% and 1.03%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Insperity, Inc. (NSP) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Insperity, Inc. (NSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights Insperity, Kforce and Cross Country Healthcare
by Zacks Equity Research
Insperity, Kforce and Cross Country Healthcare have been highlighted in this Industry Outlook article.
3 Stocks to Watch From the Promising Staffing Services Industry
by Zacks Equity Research
Re-opening of the global economy, increased dependency on technology and benefits of the ongoing hybrid working model should aid the Zacks Staffing industry. NSP, KFRC and CCRN are well poised to witness a demand surge.
Insperity (NSP) Gains 14.4% in the Past 6 Months: Here's How
by Zacks Equity Research
Top-line growth as well as continuous investor-friendly steps boost Insperity (NSP).
4 Business Services Stocks Most Wall Street Analysts Are Bullish About
by Zacks Equity Research
RTO, FUTU, INST and NSP are poised to benefit in 2023 and beyond with healthy fundamentals and solid Zacks Rank.
Zacks.com featured highlights include Archer-Daniels-Midland, Cardinal Health, Insperity, Deere & Co. and H&R Block
by Zacks Equity Research
Archer-Daniels-Midland, Cardinal Health, Insperity, Deere & Co. and H&R Block are part of the Zacks Screen of the Week.
Here's Why Investors Should Buy Insperity (NSP) Stock Now
by Zacks Equity Research
Pro-investor steps and the growing PEO industry are aiding Insperity's (NSP) stock.
5 Top-Ranked Dividend Growth Stocks for 2023
by Sweta Killa
Archer-Daniels-Midland (ADM), Cardinal Health (CAH), Insperity (NSP), Deere & Company (DE), and H&R Block (HRB) could be compelling picks for 2023.